Company / Capital Returned to Shareholders per Share
Haemonetics Capital Returned to Shareholders per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$4.46
FY2024
5-year range
$0.00 / $4.46
FY2020-FY2024
Trend
-
vs FY2023
Sector context
#33 of 103
Health Care
What the data says
At $4.46, Haemonetics's capital returned to shareholders per share ranks #33 of 103 in the Health Care sector. Capital Returned to Shareholders per Share has fluctuated over the past 9 years, ranging from $0.00 in FY2023 to $4.46 in FY2024.
Based on SEC 10-K filings.
4.46 in FY2024 with a 5-year CAGR of +5.7%.
Improved from $1.46 to $4.46 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +5.7%
- 10-Year CAGR
- -
Sector benchmark
-12.1% below sector average
Key checks
Key Insights
- Ranks #33 out of 103 companies in the Health Care sector.
- Lowest capital returned to shareholders per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $4.46 | - |
| FY2023 | $0.00 | -100.0% |
| FY2022 | $1.46 | - |
| FY2021 | $0.00 | - |
| FY2020 | $0.00 | -100.0% |
| FY2019 | $3.38 | +10.3% |
| FY2018 | $3.06 | +55.9% |
| FY2017 | $1.96 | - |
| FY2016 | $0.00 | -100.0% |
As of FY2024 · SEC 10-K · Updated Mar 28, 2026